Skip to main content

Table 2 Patient comorbid conditions (N = 2,145)

From: Utilization patterns of insulin therapy and healthcare services among Japanese insulin initiators during their first year: a descriptive analysis of administrative hospital data

Comorbid Condition (N = 2,145)

Overall (N = 2,145)

Long-acting (N = 244)

Pre-mixed (N = 118)

Rapid-acting (N = 997)

Intensive (N = 786)

Comorbid conditions, n (%)

   Hypertension

870 (40.6)

40 (16.4)

42 (35.6)

475 (47.6)

313 (39.8)

   Nephropathy

571 (26.6)

31 (12.7)

39 (33.1)

301 (30.2)

200 (25.4)

   Ischemic heart disease

398 (18.6)

28 (11.5)

18 (15.3)

212 (21.3)

140 (17.8)

   Heart failure

331 (15.4)

15 (6.1)

12 (10.2)

200 (20.1)

104 (13.2)

   Cerebrovascular disease

300 (14.0)

9 (3.7)

11 (9.3)

172 (17.3)

108 (13.7)

   Neuropathy

189 (8.8)

13 (5.3)

7 (5.9)

100 (10.0)

69 (8.8)

   Arthropathy

171 (8.0)

8 (3.3)

-

109 (10.9)

54 (6.9)

   Depression

59 (2.8)

2 (0.8)

-

36 (3.6)

21 (2.7)

   Peripheral vascular disease

54 (2.5)

5 (2.0)

1 (0.8)

26 (2.6)

22 (2.8)

   Skin complications

37 (1.7)

1 (0.4)

2 (1.7)

15 (1.5)

19 (2.4)

   Retinopathy

34 (1.6)

1 (0.4)

1 (0.8)

15 (1.5)

17 (2.2)

   Myocardial infarction

28 (1.3)

1 (0.4)

2 (1.7)

12 (1.2)

13 (1.7)

   Hypoglycemia

25 (1.2)

-

-

18 (1.8)

7 (0.9)

   Hyperglycemia

12 (0.6)

1 (0.4)

-

7 (0.7)

4 (0.5)

   Ketoacidosis

7 (0.3)

-

 

-

7 (0.9)

   Oral complications

1 (0.0)

-

-

1 (0.1)

-